PRESS RELEASE published on 01/08/2025 at 18:00, 1 year 9 months ago BASTIDE obtains an extended license to operate in Canada in the Respiratory Care segment / Sale of French stomatherapy subsidiary CICA PLUS Groupe Bastide extends respiratory care license to British Columbia, Canada, while selling French subsidiary CICA PLUS specialized in stomatherapy. The company aims to boost organic growth in Canada and improve financials Organic Growth Canada Respiratory Care Groupe Bastide CICA PLUS
BRIEF published on 01/06/2025 at 18:15, 1 year 9 months ago BASTIDE: Number of shares and voting rights as of December 31, 2024 Share Capital Voting Rights AMF Trade Bastide Actions
BRIEF published on 12/20/2024 at 15:50, 1 year 10 months ago Report of the Bastide General Meeting Shareholders General Assembly Resolutions Approved BASTIDE MEDICAL COMFORT Official Publications
BRIEF published on 12/03/2024 at 18:20, 1 year 10 months ago Update on Bastide Le Confort Médical shares and voting rights Voting Rights Actions AMF 2024 BASTIDE MEDICAL COMFORT
BRIEF published on 11/25/2024 at 18:20, 1 year 11 months ago BASTIDE: Availability of documents for the General Meeting of December 16 Shareholders General Assembly Preparatory Documents Bastide Caissargues
BRIEF published on 11/14/2024 at 18:05, 1 year 11 months ago Bastide Group: Strong performance in the first quarter of 2024-2025 Organic Growth International Health Benefits Turnover Financial Objectives
PRESS RELEASE published on 11/14/2024 at 18:00, 1 year 11 months ago Highly dynamic organic growth in Q1 2024-25 at 9.0% : 10.9% growth in home healthcare services and rebound in the homecare business, up 6.0% / Disposal of Swiss commercial business finalized and 2024-2025 targets confirmed Groupe Bastide reports solid organic growth of 9.0% in the first-quarter 2024-2025, with revenue reaching €133.8 million. Key focus on home healthcare services, international expansion, and strategic financial objectives Revenue Organic Growth Financial Objectives Groupe Bastide Home Healthcare Services
BRIEF published on 11/06/2024 at 18:20, 1 year 11 months ago Bastide Le Confort Médical: Information on Shares and Voting Rights in October 2024 Voting Rights Actions AMF BASTIDE MEDICAL COMFORT October 2024
BRIEF published on 11/04/2024 at 18:05, 1 year 11 months ago Bastide Financial Calendar 2024-2025 Financial Calendar Annual Results Turnover Bastide Group 2024-2025
PRESS RELEASE published on 11/04/2024 at 18:00, 1 year 11 months ago 2024-2025 financial calendar Groupe Bastide Le Confort Médical to report first-quarter revenue on Nov 14, 2024. Leading provider of home healthcare services since 1977, listed on Euronext Paris Euronext Paris Revenue Medical Devices Groupe Bastide Home Healthcare Services
Published on 10/24/2026 at 00:04, 1 day 21 hours ago Sparta Capital Ltd. Provides Corporate Update on Reinstatement Review, Financial Statement Corrections and Governance Matters
Published on 10/23/2026 at 23:30, 1 day 21 hours ago Algo Grande Commissions Independent NI 43-101 Update to Capture First Year of Progress at Adelita
Published on 10/23/2026 at 21:55, 1 day 23 hours ago Apex Closes Offering and Completes NASDAQ Listing
Published on 10/23/2026 at 16:00, 2 days 5 hours ago Leggett Dynamics's Mid-Class Massage System Wins Gasgoo's Best Technical Practice Award
Published on 10/24/2026 at 23:44, 22 hours 26 minutes ago EQS-Adhoc: HomeToGo SE: Unauthorized data exfiltration at subsidiary SECRA Bookings GmbH
Published on 10/24/2026 at 14:15, 1 day 6 hours ago Winners of the 2026 INPD Awards Announced, C-Beauty Takes Home Multiple Prestigious Honors
Published on 10/24/2026 at 06:30, 1 day 14 hours ago AI and EV Boom Draws $690 Million in Advanced Materials Investment Plans to Thailand
Published on 10/23/2026 at 18:55, 2 days 2 hours ago Qatar's Years of Culture Initiative Announces Partner Countries Through 2030
Published on 10/23/2026 at 18:00, 2 days 3 hours ago BIOSYNEX SA: CHEMBIO DIAGNOSTIC SYSTEMS AWARDED $5.7 MILLION TO ADVANCE DPP® BIOTHREAT PANEL
Published on 10/23/2026 at 20:33, 2 days ago Disclosure of transactions in own shares from October 19 to October 23, 2026
Published on 10/23/2026 at 17:45, 2 days 3 hours ago Imerys-10-2026-information-share-capital-and-voting-rights-as-of-30-September-2026
Published on 10/22/2026 at 18:00, 3 days 3 hours ago THERMADOR GROUPE : Completion of the share buy-back programme launched in August
Published on 10/22/2026 at 18:00, 3 days 3 hours ago bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics